Cartesian Therapeutics eliminates chief scientific officer position

Cartesian Therapeutics Inc. (NASDAQ: RNAC) eliminated the chief scientific officer position and terminated Christopher Jewell without cause, effective November 14, 2025, according to a company statement.

The company delivered the termination notice to Jewell on October 15, 2025. Jewell entered into a separation agreement with Cartesian Therapeutics on October 20, 2025.

The information was disclosed in a company filing based on the separation agreement between the parties.

You May Also Be Interested In

• Synaptics CFO resigns amid pending ON Semiconductor merger
• Robo.ai names Hao Wang of Changer.ae to its board of directors
• Crypto stocks continue rallying as Bitcoin extends gains on regulation push